Yanni Souroutzidis

Stock Analyst at Cantor Fitzgerald

(2.44)
# 2,380
Out of 5,165 analysts
1
Total ratings
100%
Success rate
17.69%
Average return
Main Sectors:
Top Industries:

Stocks Rated by Yanni Souroutzidis

Karyopharm Therapeutics
Feb 5, 2026
Initiates: Overweight
Price Target: n/a
Current: $8.55
Upside: -